Literature DB >> 19423268

A treatment algorithm for managing giant mandibular ameloblastoma: 5-year experiences in a Paris university hospital.

A Chaine1, P Pitak-Arnnop, K Dhanuthai, B Ruhin-Poncet, J-Ch Bertrand, C Bertolus.   

Abstract

AIMS: To review our experiences with giant mandibular ameloblastoma (GMA) over a 5-year period, and to formulate a treatment algorithm for managing this tumour.
METHODS: We retrospectively reviewed all GMA patients who underwent segmental mandibulectomy and immediate free fibular osteoseptocutaneous flap reconstruction (SM-IFFOFR) by a single reconstructive team from 2002 to 2006. All treatment methods and outcomes were analysed.
FINDINGS: Forty-four ameloblastoma patients were operated upon during this study period. Sixteen cases had GMA, of which 9 patients were included in this series (mean age: 35 years). The defects in the mandible ranged from 7 to 16 cm in length (mean: 12 cm). The average length of the harvested fibula was 11 cm, and the number of osteotomies ranged from 1 to 2. The mean ischemic time was 137 min (range: 90-180 min). Neck recipient vessels were used for flap perfusion in all cases. All but one flaps were viable without any complications, whilst partial skin-island necrosis occurred in 2 patients. Hospital stay was 2 weeks in most of the patients. No tumour recurrence was found during the follow-up period (range: 26-73 months). Dental implants were placed in 2 patients.
CONCLUSIONS: Despite several limitations of this study, we suggest that a radical approach with the SM-IFFOFR is an effective treatment for GMA. Further well-designed, larger series with longer follow-up periods are still encouraged.

Entities:  

Mesh:

Year:  2009        PMID: 19423268     DOI: 10.1016/j.ejso.2009.04.006

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

1.  Enucleation of keratocystic odontogenic tumours: study interpretation, technical refinement and future research.

Authors:  Poramate Pitak-Arnnop
Journal:  Clin Oral Investig       Date:  2010-09-14       Impact factor: 3.573

2.  Is conservative surgery a better choice for the solid/multicystic ameloblastoma than radical surgery regarding recurrence? A systematic review.

Authors:  Yuri Slusarenko da Silva; Natalia Aguiar Tartaroti; Daniel Isaac Sendyk; Maria Cristina Zindel Deboni; Maria da Graça Naclério-Homem
Journal:  Oral Maxillofac Surg       Date:  2018-09-06

3.  Unicystic ameloblastoma of the maxillary sinus: Pitfalls of diagnosis and management.

Authors:  P Pitak-Arnnop; A Chaine; K Dhanuthai; J C Bertrand; C Bertolus
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471

Review 4.  Mini-plate versus reconstruction bar fixation for oncologic mandibular reconstruction with free fibula flaps: A systematic review and meta-analysis.

Authors:  Nikhil Sobti; Kaleem S Ahmed; Thais Polanco; Marina Chilov; Marc A Cohen; Jay Boyle; Farooq Shahzad; Evan Matros; Jonas A Nelson; Robert J Allen
Journal:  J Plast Reconstr Aesthet Surg       Date:  2022-05-06       Impact factor: 3.022

5.  Versatility of Fibula Free Flap in Reconstruction of Facial Defects: A Center Study.

Authors:  Sunil S Shroff; Sanjiv C Nair; Anjan Shah; Balasubramanya Kumar
Journal:  J Maxillofac Oral Surg       Date:  2016-06-09

6.  Recurrent Ameloblastoma: A Surgical Challenge.

Authors:  Chithra Aramanadka; Abhay Taranath Kamath; Adarsh Kudva
Journal:  Case Rep Dent       Date:  2018-02-21

7.  Clinical evaluation of fenestration decompression combined with secondary curettage for ameloblastoma of the jaw: retrospective radiographic analysis.

Authors:  Kailiu Wu; Hao Luo; Zhuang Yuan; Yanan Wang; Xing Qin; Jie He
Journal:  BMC Oral Health       Date:  2022-10-14       Impact factor: 3.747

8.  Treatment of recurrent mandibular ameloblastoma.

Authors:  Pedro Infante-Cossio; Victoria Prats-Golczer; Luis-Miguel Gonzalez-Perez; Rodolfo Belmonte-Caro; Rafael Martinez-DE-Fuentes; Eusebio Torres-Carranza; Purificacion Gacto-Sanchez; Tomas Gomez-Cia
Journal:  Exp Ther Med       Date:  2013-06-18       Impact factor: 2.447

9.  Defining giant mandibular ameloblastomas - Is a separate clinical sub-entity warranted?

Authors:  Aditya V Kanoi; Tibar Banerjee; Narayanamurthy Sundaramurthy; Arindam Sarkar; Pooja Kanoi; Sushovan Saha
Journal:  Indian J Plast Surg       Date:  2018 May-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.